Feasibility of a Self-performed Urinary Test for the Follow-up on Medical Abortion

Nordic Pharma

Status: Completed

Conditions: Abortion; Attempted, Medical

Study type: Observational

Funder types: Industry

Identifiers

NCT02304835

BETINA

Details and patient eligibility

About

This study was a national, longitudinal, prospective, observational survey, carried out in metropolitan France, with a sampling of 21 birth control centres.

The aim of this study was to assess, in real life conditions, the benefit of a urinary semi-quantitative test (hCG Duo 5-1000) in the follow-up of medical abortion by analysing the concordance between qualitative results from the urinary test and quantitative values from the beta-hCG blood measurement.

Enrollment: 322 patients

Sex: Female

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Adult women (18 years old or more), pregnant the day of the medical examination and asking for medical abortion.
• Patients agreeing to participate in the study after have been informed orally by the physician and given the information sheet.
• Informed patients accepting the computer processing of their medical data and their right of access and correction.

Exclusion criteria

• Patients with more than 49 Days of Amenorrhea (DA) for private practice and 63 DA for hospital practice.
• Patients with contraindications to medical abortion.
• Patients with severe and progressive disease.
• Patients unable to complete a questionnaire.
• Patients refusing to participate in the study.